Avidity Biosciences RNA Stock
Avidity Biosciences Price Chart
Avidity Biosciences RNA Financial and Trading Overview
| Avidity Biosciences stock price | 25.76 USD |
| Previous Close | 12.19 USD |
| Open | 12.19 USD |
| Bid | 0 USD x 800 |
| Ask | 0 USD x 900 |
| Day's Range | 12.15 - 12.71 USD |
| 52 Week Range | 9.83 - 25.74 USD |
| Volume | 4.37M USD |
| Avg. Volume | 1.41M USD |
| Market Cap | 883.82M USD |
| Beta (5Y Monthly) | -0.097524 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.89 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 37 USD |
RNA Valuation Measures
| Enterprise Value | 287.09M USD |
| Trailing P/E | N/A |
| Forward P/E | -3.6814158 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 91.47418 |
| Price/Book (mrq) | 1.5811478 |
| Enterprise Value/Revenue | 29.713 |
| Enterprise Value/EBITDA | -1.431 |
Trading Information
Avidity Biosciences Stock Price History
| Beta (5Y Monthly) | -0.097524 |
| 52-Week Change | -2.80% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 25.74 USD |
| 52 Week Low | 9.83 USD |
| 50-Day Moving Average | 12.67 USD |
| 200-Day Moving Average | 17.11 USD |
RNA Share Statistics
| Avg. Volume (3 month) | 1.41M USD |
| Avg. Daily Volume (10-Days) | 1.31M USD |
| Shares Outstanding | 70.82M |
| Float | 54.79M |
| Short Ratio | 10.96 |
| % Held by Insiders | 5.17% |
| % Held by Institutions | 102.96% |
| Shares Short | 13.4M |
| Short % of Float | 19.17% |
| Short % of Shares Outstanding | 18.92% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -2091.17% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -24.39% |
| Return on Equity (ttm) | -41.11% |
Income Statement
| Revenue (ttm) | 9.66M USD |
| Revenue Per Share (ttm) | 0.17 USD |
| Quarterly Revenue Growth (yoy) | 24.39% |
| Gross Profit (ttm) | -141180000 USD |
| EBITDA | -200584992 USD |
| Net Income Avi to Common (ttm) | -192154000 USD |
| Diluted EPS (ttm) | -3.38 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 586.3M USD |
| Total Cash Per Share (mrq) | 8.28 USD |
| Total Debt (mrq) | 10.11M USD |
| Total Debt/Equity (mrq) | 1.81 USD |
| Current Ratio (mrq) | 12.419 |
| Book Value Per Share (mrq) | 7.893 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -155660992 USD |
| Levered Free Cash Flow (ttm) | -85234624 USD |
Profile of Avidity Biosciences
| Country | United States |
| State | CA |
| City | San Diego |
| Address | 10578 Science Center Drive |
| ZIP | 92121 |
| Phone | 858 401 7900 |
| Website | https://www.aviditybiosciences.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 186 |
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 for the treatment of myotonic dystrophy type 1, a rare monogenic muscle disease is under phase 1/2 clinical trial. Its other products in pipeline include AOC 1044 for the treatment of Duchenne Muscular Dystrophy, which is under phase 1/2 clinical trial; and AOC 1020 to treat facioscapulohumeral muscular dystrophy is in phase 1/2 clinical trial. Avidity Biosciences, Inc. was incorporated in 2012 and is headquartered in San Diego, California.
Q&A For Avidity Biosciences Stock
What is a current RNA stock price?
Avidity Biosciences RNA stock price today per share is 25.76 USD.
How to purchase Avidity Biosciences stock?
You can buy RNA shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Avidity Biosciences?
The stock symbol or ticker of Avidity Biosciences is RNA.
Which industry does the Avidity Biosciences company belong to?
The Avidity Biosciences industry is Biotechnology.
How many shares does Avidity Biosciences have in circulation?
The max supply of Avidity Biosciences shares is 120.21M.
What is Avidity Biosciences Price to Earnings Ratio (PE Ratio)?
Avidity Biosciences PE Ratio is now.
What was Avidity Biosciences earnings per share over the trailing 12 months (TTM)?
Avidity Biosciences EPS is -2.89 USD over the trailing 12 months.
Which sector does the Avidity Biosciences company belong to?
The Avidity Biosciences sector is Healthcare.
Avidity Biosciences RNA included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16307.16 USD — |
-3.07
|
7.08B USD — | 16066.46 USD — | 16600.37 USD — | — - | 7.08B USD — |
| NASDAQ Global Market Composite NQGM | 1727.53 USD — |
-1.77
|
— — | 1703.28 USD — | 1740.16 USD — | — - | — — |
| NASDAQ Biotechnology NBI | 3931.86 USD — |
-1.96
|
— — | 3898 USD — | 4000.18 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 882.43 USD — |
-1.77
|
— — | 875.25 USD — | 895.82 USD — | — - | — — |
| Nasdaq US 700 Small Cap Index NQUS700SC | 1966.83 USD — |
-0.91
|
— — | 1943.77 USD — | 1985.27 USD — | — - | — — |
| Stlmt ID NASDAQ Biotechnology NBX | 4604.4 USD — |
-2.98
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
- {{ link.label }} {{link}}